Edgemond WS[au] - Search Results

Year	Number of Results
1995	3
1996	1
1997	2
1998	5
2000	1
2022	0

1

Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain.

Hillard CJ, Wilkison DM, Edgemond WS, Campbell WB. Hillard CJ, et al. Among authors: edgemond ws. Biochim Biophys Acta. 1995 Aug 3;1257(3):249-56. doi: 10.1016/0005-2760(95)00087-s. Biochim Biophys Acta. 1995. PMID: 7647100

2

N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor.

Pratt PF, Hillard CJ, Edgemond WS, Campbell WB. Pratt PF, et al. Among authors: edgemond ws. Am J Physiol. 1998 Jan;274(1):H375-81. doi: 10.1152/ajpheart.1998.274.1.H375. Am J Physiol. 1998. PMID: 9458889

3

Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion.

Hillard CJ, Edgemond WS, Jarrahian A, Campbell WB. Hillard CJ, et al. Among authors: edgemond ws. J Neurochem. 1997 Aug;69(2):631-8. doi: 10.1046/j.1471-4159.1997.69020631.x. J Neurochem. 1997. PMID: 9231721 Free article.

4

Identification of the 11,14,15- and 11,12, 15-trihydroxyeicosatrienoic acids as endothelium-derived relaxing factors of rabbit aorta.

Pfister SL, Spitzbarth N, Nithipatikom K, Edgemond WS, Falck JR, Campbell WB. Pfister SL, et al. Among authors: edgemond ws. J Biol Chem. 1998 Nov 20;273(47):30879-87. doi: 10.1074/jbc.273.47.30879. J Biol Chem. 1998. PMID: 9812980 Free article.

5

Selective effects of the endogenous cannabinoid arachidonylethanolamide (anandamide) on regional cerebral blood flow in the rat.

Stein EA, Fuller SA, Edgemond WS, Campbell WB. Stein EA, et al. Among authors: edgemond ws. Neuropsychopharmacology. 1998 Dec;19(6):481-91. doi: 10.1016/S0893-133X(98)00043-8. Neuropsychopharmacology. 1998. PMID: 9803424

6

Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation.

Edgemond WS, Hillard CJ, Falck JR, Kearn CS, Campbell WB. Edgemond WS, et al. Mol Pharmacol. 1998 Jul;54(1):180-8. doi: 10.1124/mol.54.1.180. Mol Pharmacol. 1998. PMID: 9658204

7

Synthesis and characterization of diazomethylarachidonyl ketone: an irreversible inhibitor of N-arachidonylethanolamine amidohydrolase.

Edgemond WS, Greenberg MJ, McGinley PJ, Muthian S, Campbell WB, Hillard CJ. Edgemond WS, et al. J Pharmacol Exp Ther. 1998 Jul;286(1):184-90. J Pharmacol Exp Ther. 1998. PMID: 9655859

8

Nonclassical and endogenous cannabinoids: effects on the ordering of brain membranes.

Bloom AS, Edgemond WS, Moldvan JC. Bloom AS, et al. Among authors: edgemond ws. Neurochem Res. 1997 May;22(5):563-8. doi: 10.1023/a:1022413901857. Neurochem Res. 1997. PMID: 9131634

9

Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter.

Jarrahian A, Manna S, Edgemond WS, Campbell WB, Hillard CJ. Jarrahian A, et al. Among authors: edgemond ws. J Neurochem. 2000 Jun;74(6):2597-606. doi: 10.1046/j.1471-4159.2000.0742597.x. J Neurochem. 2000. PMID: 10820223 Free article.

10

The binding of novel phenolic derivatives of anandamide to brain cannabinoid receptors.

Edgemond WS, Campbell WB, Hillard CJ. Edgemond WS, et al. Prostaglandins Leukot Essent Fatty Acids. 1995 Feb-Mar;52(2-3):83-6. doi: 10.1016/0952-3278(95)90002-0. Prostaglandins Leukot Essent Fatty Acids. 1995. PMID: 7784462

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results